文献速递银屑病与炎症性皮肤病

银屑病患者接受肿瘤坏死因子-α抑制剂与光疗的心血管事件风险:一项观察性队列研究

The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort study.
PubMed 文献 · J Am Acad Dermatol · 2018-03-01

基于美国大型行政索赔数据库(2000年第一季度至2014年第三季度)的观察性队列研究,纳入11410例TNFi治疗和12433例光疗的成人银屑病患者。TNFi组心血管事件风险低于光疗组(校正风险比0.77,P<.05);6个月累积暴露相关的风险降低幅度TNFi组比光疗组大11.2%(P<.05)。

要点

  • TNFi组心血管事件风险低于光疗组(校正风险比0.77,P<.05)。
  • 6个月累积暴露相关风险降低幅度TNFi组比光疗组大11.2%(P<.05)。
  • 光疗组包括PUVA 1117例和UVB 11316例。

核心结论

  • 接受TNFi治疗的银屑病患者心血管事件风险低于接受光疗的患者。
  • 与光疗相比,TNFi累积暴露与递增的心血管风险降低相关。

研究设计与样本

  • 观察性队列研究,成人银屑病患者选自美国大型行政索赔数据库(2000年第一季度至2014年第三季度)。
  • 患者按接受TNFi或光疗分为两个互斥队列,采用多变量Cox比例风险模型比较心血管事件风险。
  • 共纳入11410例TNFi患者和12433例光疗患者(PUVA n=1117;UVB n=11316)。
  • 累积暴露基于治疗持续性定义。

主要发现

  • TNFi组心血管事件风险低于光疗组(校正风险比0.77,P<.05)。
  • 6个月累积暴露相关的风险降低幅度TNFi组比光疗组大11.2%(P<.05)。

局限性

  • 银屑病严重程度和死亡率信息有限或不可获得。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is a risk factor for cardiovascular events. OBJECTIVE: To assess the risk of major cardiovascular events and the effect of cumulative treatment exposure on cardiovascular event risk in patients with psoriasis treated with tumor necrosis factor-α inhibitors (TNFis) versus phototherapy. METHODS: Adult patients with psoriasis were selected from a large US administrative claims database (from the first quarter of 2000 through the third quarter of 2014) and classified in 2 mutually exclusive cohorts based on whether they were treated with TNFis or phototherapy. Cardiovascular event risk was compared between cohorts using multivariate Cox proportional hazards models. Cumulative exposure was defined based on treatment persistence. RESULTS: A total of 11,410 TNFi and 12,433 phototherapy patients (psoralen plus ultraviolet A light phototherapy, n = 1117; ultraviolet B light phototherapy, n = 11,316) were included in this study. TNFi patients had a lower risk of cardiovascular events compared to phototherapy patients (adjusted hazard ratio 0.77, P < .05). The risk reduction associated with 6 months of cumulative exposure was 11.2% larger for patients treated with TNFis compared to phototherapy (P < .05). LIMITATIONS: Information on psoriasis severity and mortality was limited/not available. CONCLUSIONS: Patients with psoriasis who were treated with TNFis exhibited a lower cardiovascular event risk than patients treated with phototherapy. Cumulative exposure to TNFis was associated with an incremental cardiovascular risk reduction compared to phototherapy.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Wu JJ, Sundaram M, Cloutier M, et al. The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort study. J Am Acad Dermatol. 2018. PMID: 29499292. doi:10.1016/j.jaad.2018.02.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。